Phase 2 pharmacological experimental study to test the safety of miglustat in subjects with hereditary spastic paraplegia type 11

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2021
This article has no abstract
Epistemonikos ID: 3d2ef6418dae0d93bfd277eb1314d45aa5b3626c
First added on: Jan 23, 2025